{"id":5644,"date":"2026-02-12T12:36:11","date_gmt":"2026-02-12T12:36:11","guid":{"rendered":"https:\/\/regenerated.health\/sibo-symptoms\/"},"modified":"2026-06-25T14:31:13","modified_gmt":"2026-06-25T14:31:13","slug":"sibo-symptoms","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/sibo-symptoms\/","title":{"rendered":"SIBO Symptoms: Signs of Small Intestinal Bacterial Overgrowth and What to Do About Them"},"content":{"rendered":"\n<div class=\"at-a-glance\">\n<h2>At a Glance<\/h2>\n<ul>\n<li>SIBO occurs when bacteria that normally live in the colon migrate into and overpopulate the small intestine<\/li>\n<li>The hallmark symptoms are bloating within 30-90 minutes of eating, excessive gas, and altered bowel habits (diarrhea, constipation, or both)<\/li>\n<li>Less obvious symptoms include brain fog, fatigue, nutrient deficiencies (B12, iron, fat-soluble vitamins), and skin problems<\/li>\n<li>Up to 78% of patients diagnosed with IBS may actually have SIBO as the underlying cause<\/li>\n<li>SIBO is diagnosed via lactulose or glucose breath testing, and treatment targets both the overgrowth and the root cause that allowed it to develop<\/li>\n<\/ul>\n<\/div>\n\n<h2>What Is SIBO?<\/h2>\n\n<p>Your small intestine is designed to be relatively low in bacteria. Most of your gut bacteria (trillions of them) belong in the large intestine, where they ferment fiber, produce short-chain fatty acids, and support immune function. SIBO (small intestinal bacterial overgrowth) happens when bacteria from the colon or other areas colonize the small intestine in abnormally high numbers [1].<\/p>\n\n<p>The small intestine has several protective mechanisms to keep bacterial counts low: stomach acid kills many incoming organisms, bile has antimicrobial properties, the migrating motor complex (MMC) sweeps bacteria downward between meals, and the ileocecal valve acts as a physical barrier between the small and large intestine. When any of these defenses fail, bacteria proliferate where they should not [2].<\/p>\n\n<p>Once bacteria take up residence in the small intestine, they ferment carbohydrates that are meant to be absorbed there, not fermented. This produces hydrogen, methane, or hydrogen sulfide gas, and it is this gas production in the wrong location that drives most SIBO symptoms.<\/p>\n\n<h2>The Three Types of SIBO<\/h2>\n\n<p>Not all SIBO is the same. The type of gas the overgrown organisms produce determines which symptoms predominate [3]:<\/p>\n\n<ul>\n<li><strong>Hydrogen-dominant SIBO:<\/strong> Caused by bacteria that produce hydrogen gas. Tends to cause diarrhea, urgency, and abdominal cramping.<\/li>\n<li><strong>Methane-dominant SIBO (now called intestinal methanogen overgrowth, or IMO):<\/strong> Caused by archaea (primarily Methanobrevibacter smithii) rather than bacteria. Methane slows intestinal transit, leading to constipation, hard stools, and straining. The term IMO is more accurate because these organisms can overgrow in the large intestine as well [4].<\/li>\n<li><strong>Hydrogen sulfide-dominant SIBO:<\/strong> A more recently characterized form. Hydrogen sulfide is produced by sulfate-reducing bacteria and is associated with diarrhea, particularly foul-smelling gas and stool, and sometimes visceral pain [5].<\/li>\n<\/ul>\n\n<h2>Classic SIBO Symptoms<\/h2>\n\n<h3>Bloating and Abdominal Distension<\/h3>\n\n<p>This is the single most common symptom of SIBO and often the most disruptive. The bloating typically begins 30 to 90 minutes after eating, as bacteria in the small intestine start fermenting the carbohydrates from your meal. It tends to worsen throughout the day and is often worst after dinner. Many patients describe looking &#8220;six months pregnant&#8221; by evening.<\/p>\n\n<p>What makes SIBO bloating different from normal post-meal fullness is its severity and predictability. It happens reliably after meals (especially those containing fermentable carbohydrates), and it is often accompanied by visible abdominal distension that can be measured in inches [6].<\/p>\n\n<h3>Excessive Gas<\/h3>\n\n<p>Both belching and flatulence are common. The gas is produced by bacterial fermentation in the small intestine, and because the small intestine was not designed to handle large volumes of gas, patients often experience uncomfortable pressure and cramping along with it. Some patients report that the gas has a sulfurous or rotten-egg odor, which points toward hydrogen sulfide-producing organisms.<\/p>\n\n<h3>Diarrhea<\/h3>\n\n<p>Diarrhea is the predominant bowel pattern in hydrogen-dominant SIBO. The mechanisms are straightforward: bacterial fermentation produces osmotically active substances that draw water into the intestinal lumen, and bacterial metabolism of bile acids (deconjugation) impairs fat absorption, leading to loose, sometimes greasy stools [7]. Some patients experience urgency and need to use the bathroom multiple times in the morning.<\/p>\n\n<h3>Constipation<\/h3>\n\n<p>When methane-producing archaea dominate, the pattern shifts to constipation. Methane gas directly slows smooth muscle contraction in the gut wall. Studies using gas infusion have shown that methane reduces intestinal transit time by up to 59% [4]. Patients with methane-dominant overgrowth typically report infrequent bowel movements, hard stools, excessive straining, and a feeling of incomplete evacuation.<\/p>\n\n<h3>Abdominal Pain and Cramping<\/h3>\n\n<p>Pain in SIBO is usually diffuse or located in the mid-abdomen (periumbilical area), which corresponds to the location of the small intestine. It is often described as crampy, pressure-like, or a &#8220;tight band&#8221; sensation. The pain tends to come on after eating and may partially improve after passing gas or having a bowel movement.<\/p>\n\n<h3>Nausea<\/h3>\n\n<p>Nausea is reported by roughly 30-40% of SIBO patients. It can be related to delayed gastric emptying (gastroparesis), which frequently coexists with SIBO, or it may result from the inflammatory effects of bacterial metabolites on the upper GI tract [8].<\/p>\n\n<h2>Less Obvious SIBO Symptoms<\/h2>\n\n<p>SIBO affects more than just the gut. Bacterial overgrowth in the small intestine triggers systemic inflammation, impairs nutrient absorption, and disrupts the gut-brain axis. This produces a range of symptoms that many patients (and some clinicians) do not immediately connect to a gut problem.<\/p>\n\n<h3>Brain Fog and Cognitive Issues<\/h3>\n\n<p>Many SIBO patients report difficulty concentrating, mental &#8220;cloudiness,&#8221; and short-term memory problems. A 2018 study found that patients with brain fog were significantly more likely to have SIBO, and that brain fog improved or resolved after antibiotic treatment of the overgrowth [9]. The proposed mechanisms include D-lactic acidosis from bacterial metabolism, systemic inflammation crossing the blood-brain barrier, and nutrient deficiencies (particularly B12 and iron) that impair cognitive function.<\/p>\n\n<h3>Fatigue<\/h3>\n\n<p>Chronic, often debilitating fatigue is one of the most common extra-intestinal symptoms. This goes beyond normal tiredness. Patients describe it as a deep exhaustion that is not proportional to their activity level and does not improve with sleep. Contributing factors include malabsorption of energy-producing nutrients, chronic low-grade immune activation, and the metabolic cost of managing ongoing inflammation.<\/p>\n\n<h3>Nutrient Deficiencies<\/h3>\n\n<p>Bacteria in the small intestine compete with you for nutrients and can damage the absorptive surface of the intestinal lining. Common deficiencies in SIBO include [10]:<\/p>\n\n<ul>\n<li><strong>Vitamin B12:<\/strong> Bacteria consume B12 before it can be absorbed. Low B12 causes fatigue, neuropathy (tingling, numbness), and cognitive impairment.<\/li>\n<li><strong>Iron:<\/strong> Bacterial overgrowth can cause iron malabsorption, leading to anemia.<\/li>\n<li><strong>Fat-soluble vitamins (A, D, E, K):<\/strong> Bacterial deconjugation of bile acids impairs fat absorption, and fat-soluble vitamins go unabsorbed along with dietary fats. Low vitamin D is particularly common.<\/li>\n<li><strong>Magnesium and zinc:<\/strong> Malabsorption from inflamed intestinal mucosa.<\/li>\n<\/ul>\n\n<h3>Skin Issues<\/h3>\n\n<p>The gut-skin axis is a real phenomenon. SIBO has been associated with rosacea (one study found SIBO in 46% of rosacea patients, and antibiotic treatment cleared skin symptoms in most), acne, and eczema [11]. The proposed link involves increased intestinal permeability (&#8220;leaky gut&#8221;), systemic inflammation, and immune dysregulation triggered by bacterial translocation products like lipopolysaccharides (LPS).<\/p>\n\n<h3>Joint Pain<\/h3>\n\n<p>Some SIBO patients develop joint pain or body aches that do not have an obvious orthopedic explanation. This likely relates to circulating inflammatory mediators and increased intestinal permeability allowing bacterial endotoxins into the bloodstream.<\/p>\n\n<h3>Mood Changes<\/h3>\n\n<p>Anxiety and depression co-occur with SIBO at higher rates than the general population. The gut produces roughly 90% of the body&#8217;s serotonin, and SIBO-related inflammation and dysbiosis can disrupt serotonin synthesis. Nutrient deficiencies (B12, iron, vitamin D) also contribute to mood disturbances [12].<\/p>\n\n<h2>SIBO and IBS: The Overlap<\/h2>\n\n<p>The symptom overlap between SIBO and IBS is enormous. Bloating, gas, abdominal pain, diarrhea, and constipation are defining features of both conditions. This has led to a long-running debate about whether SIBO is a cause of IBS, a subset of IBS, or a separate condition that simply looks like it.<\/p>\n\n<p>Research suggests the relationship is significant. A meta-analysis found that SIBO is present in 36% of IBS patients by breath testing (compared to about 15% of healthy controls), though some studies report prevalence as high as 78% depending on the testing method and diagnostic threshold used [13]. The landmark TARGET trials showed that the antibiotic rifaximin (which treats SIBO) significantly improved IBS-D symptoms, and the FDA subsequently approved rifaximin for IBS-D treatment [14].<\/p>\n\n<p>The practical takeaway: if you have been diagnosed with IBS, particularly if your primary symptoms are bloating and your symptoms worsen predictably after eating, ask your clinician about SIBO testing.<\/p>\n\n<h2>When to Suspect SIBO<\/h2>\n\n<p>Consider SIBO testing if you have:<\/p>\n\n<ul>\n<li>Chronic bloating that starts within 30-90 minutes after meals<\/li>\n<li>IBS symptoms that have not responded to standard dietary modifications (low FODMAP, fiber adjustments)<\/li>\n<li>Unexplained nutrient deficiencies, particularly low B12, iron, or vitamin D<\/li>\n<li>A history of conditions that predispose to SIBO (see below)<\/li>\n<li>Brain fog or fatigue that seems to correlate with GI symptoms<\/li>\n<li>Symptoms that temporarily improve on antibiotics prescribed for other reasons<\/li>\n<li>Rosacea or other skin conditions alongside GI symptoms<\/li>\n<\/ul>\n\n<h2>Conditions That Predispose to SIBO<\/h2>\n\n<p>SIBO rarely develops without an underlying predisposing factor. Knowing these risk factors helps guide testing decisions and treatment planning:<\/p>\n\n<ul>\n<li><strong>Low stomach acid:<\/strong> From proton pump inhibitors (PPIs), autoimmune gastritis, or aging. Stomach acid is a major defense against bacterial migration [15].<\/li>\n<li><strong>Impaired motility:<\/strong> Conditions like diabetes, hypothyroidism, scleroderma, Ehlers-Danlos syndrome, or post-surgical adhesions slow the migrating motor complex.<\/li>\n<li><strong>Structural abnormalities:<\/strong> Prior abdominal surgery, small bowel diverticula, strictures, or ileocecal valve dysfunction.<\/li>\n<li><strong>Immune deficiency:<\/strong> IgA deficiency, chronic steroid use, or immunosuppressive medications.<\/li>\n<li><strong>Chronic opioid use:<\/strong> Opioids dramatically slow intestinal motility.<\/li>\n<li><strong>Post-infectious IBS:<\/strong> Food poisoning can damage the interstitial cells of Cajal and the MMC through autoantibody production (anti-vinculin and anti-CdtB antibodies).<\/li>\n<\/ul>\n\n<h2>How SIBO Connects to Other Conditions<\/h2>\n\n<p>SIBO does not exist in isolation. It frequently overlaps with and can trigger or worsen other conditions:<\/p>\n\n<ul>\n<li><strong>Mast cell activation syndrome (MCAS):<\/strong> Bacterial overgrowth can trigger mast cell degranulation in the gut, worsening histamine-related symptoms.<\/li>\n<li><strong>Hypothyroidism:<\/strong> Low thyroid function slows motility, predisposing to SIBO. Conversely, SIBO can impair thyroid hormone conversion through nutrient deficiencies and inflammation.<\/li>\n<li><strong>Restless legs syndrome:<\/strong> Linked to SIBO through iron malabsorption and systemic inflammation.<\/li>\n<li><strong>Fibromyalgia:<\/strong> SIBO prevalence is elevated in fibromyalgia patients, and some studies show symptom improvement with SIBO treatment.<\/li>\n<\/ul>\n\n<h2>Next Steps<\/h2>\n\n<p>If you recognize a cluster of these symptoms in yourself, the first step is breath testing. A lactulose or glucose breath test can identify hydrogen and methane overgrowth. Newer tri-gas breath tests can also detect hydrogen sulfide. Testing should be done after a 24-hour preparatory diet and an overnight fast for accurate results.<\/p>\n\n<p>A positive breath test, combined with a matching symptom profile and clinical history, provides the foundation for a targeted treatment plan. SIBO is treatable, but successful outcomes depend on addressing both the overgrowth itself and the underlying cause that allowed it to develop.<\/p>\n\n<h2>Related Reading<\/h2>\n<ul>\n<li><a href=\"\/blog\/sibo\/\">SIBO: Complete Guide<\/a><\/li>\n<li><a href=\"\/blog\/sibo-treatment\/\">SIBO Treatment: Antibiotics, Herbal Protocols, and Root Cause Strategies<\/a><\/li>\n<li><a href=\"\/blog\/sibo-diet\/\">SIBO Diet: What to Eat During and After Treatment<\/a><\/li>\n<\/ul>\n\n<h2>References<\/h2>\n<ol>\n<li>Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. <em>Gastroenterol Hepatol (N Y)<\/em>. 2007;3(2):112-122. PMID: 21960820<\/li>\n<li>Quigley EMM. The spectrum of small intestinal bacterial overgrowth (SIBO). <em>Curr Gastroenterol Rep<\/em>. 2019;21(1):3. doi:10.1007\/s11894-019-0671-z<\/li>\n<li>Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. <em>Am J Gastroenterol<\/em>. 2020;115(2):165-178. doi:10.14309\/ajg.0000000000000501<\/li>\n<li>Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. <em>Am J Physiol Gastrointest Liver Physiol<\/em>. 2006;290(6):G1089-G1095. doi:10.1152\/ajpgi.00574.2004<\/li>\n<li>Singer-Englar T, Rezaie A, Guo-Cheng Y, et al. Competitive hydrogen gas utilization by hydrogen sulfide and methane producing microorganisms and associated symptoms. <em>Dig Dis Sci<\/em>. 2022;67(7):3211-3218. doi:10.1007\/s10620-021-07135-5<\/li>\n<li>Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. <em>Ther Adv Chronic Dis<\/em>. 2013;4(5):223-231. doi:10.1177\/2040622313496126<\/li>\n<li>Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. <em>World J Gastroenterol<\/em>. 2010;16(24):2978-2990. doi:10.3748\/wjg.v16.i24.2978<\/li>\n<li>Roland BC, Ciarleglio MM, Clarke JO, et al. Small intestinal transit time is delayed in small intestinal bacterial overgrowth. <em>J Clin Gastroenterol<\/em>. 2015;49(7):571-576. doi:10.1097\/MCG.0000000000000257<\/li>\n<li>Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. <em>Clin Transl Gastroenterol<\/em>. 2018;9(6):162. doi:10.1038\/s41424-018-0030-7<\/li>\n<li>Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. <em>Aliment Pharmacol Ther<\/em>. 2017;45(5):604-616. doi:10.1111\/apt.13928<\/li>\n<li>Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. <em>Clin Gastroenterol Hepatol<\/em>. 2008;6(7):759-764. doi:10.1016\/j.cgh.2008.02.054<\/li>\n<li>Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. <em>Gut Liver<\/em>. 2017;11(2):196-208. doi:10.5009\/gnl16126<\/li>\n<li>Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. <em>Aliment Pharmacol Ther<\/em>. 2013;38(8):925-934. doi:10.1111\/apt.12479<\/li>\n<li>Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. <em>N Engl J Med<\/em>. 2011;364(1):22-32. doi:10.1056\/NEJMoa1004409<\/li>\n<li>Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. <em>Clin Gastroenterol Hepatol<\/em>. 2013;11(5):483-490. doi:10.1016\/j.cgh.2012.12.011<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Small intestinal bacterial overgrowth causes bloating, gas, and diarrhea, but it can also trigger brain fog, fatigue, and nutrient deficiencies. Here&#8217;s how to recognize the full picture.<\/p>\n","protected":false},"author":1,"featured_media":6502,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1008],"tags":[],"class_list":["post-5644","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gut-health-digestive"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5644"}],"version-history":[{"count":1,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5644\/revisions"}],"predecessor-version":[{"id":5831,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5644\/revisions\/5831"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6502"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}